BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 7144734)

  • 1. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Yamakado T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):408-12. PubMed ID: 6897280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symmetric covalent linkage of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) results in novel derivatives with increased inhibitory activities against calcium/calmodulin complex.
    Yokokura H; Osawa M; Inoue T; Umezawa I; Naito Y; Ikura M; Hidaka H
    Drug Des Discov; 1999 Nov; 16(3):203-16. PubMed ID: 10624566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of calmodulin function and of Ca2+-induced smooth muscle contraction by the calmodulin antagonist, HT-74.
    Tanaka T; Umekawa H; Saitoh M; Ishikawa T; Shin T; Ito M; Itoh H; Kawamatsu Y; Sugihara H; Hidaka H
    Mol Pharmacol; 1986 Mar; 29(3):264-9. PubMed ID: 3005834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
    Inagaki M; Kawamoto S; Itoh H; Saitoh M; Hagiwara M; Takahashi J; Hidaka H
    Mol Pharmacol; 1986 Jun; 29(6):577-81. PubMed ID: 2872589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the acrosome reaction of sea urchin spermatozoa by a calmodulin antagonist, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7).
    Sano K
    J Exp Zool; 1983 Jun; 226(3):471-3. PubMed ID: 6886669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calmodulin antagonists enhance calcium binding to calmodulin.
    Inagaki M; Tanaka T; Hidaka H
    Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calmodulin antagonists' binding sites on calmodulin.
    Tanaka T; Ohmura T; Hidaka H
    Pharmacology; 1983; 26(5):249-57. PubMed ID: 6304789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin.
    Ohki S; Ikura M; Zhang M
    Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of calmodulin-W-7 complex: the basis of diversity in molecular recognition.
    Osawa M; Swindells MB; Tanikawa J; Tanaka T; Mase T; Furuya T; Ikura M
    J Mol Biol; 1998 Feb; 276(1):165-76. PubMed ID: 9514729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of calmodulin in platelet aggregation. Structure-activity relationship of calmodulin antagonists.
    Nishikawa M; Hidaka H
    J Clin Invest; 1982 Jun; 69(6):1348-55. PubMed ID: 7085878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts.
    Zhang SP; Prozialeck WC; Weiss B
    Mol Pharmacol; 1990 Nov; 38(5):698-704. PubMed ID: 2146488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorimetric studies of calmodulin interactions with antiestrogens.
    Fanidi A; Guichard Y; Fayard JM; Pageaux JF; Laugier C
    Cancer Detect Prev; 1994; 18(6):471-8. PubMed ID: 7867020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-dependent and -independent interactions of the calmodulin-binding domain of cyclic nucleotide phosphodiesterase with calmodulin.
    Yuan T; Walsh MP; Sutherland C; Fabian H; Vogel HJ
    Biochemistry; 1999 Feb; 38(5):1446-55. PubMed ID: 9931009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide(W-7), a calmodulin antagonist, also inhibits phospholipid-sensitive calcium-dependent protein kinase.
    Schatzman RC; Raynor RL; Kuo JF
    Biochim Biophys Acta; 1983 Jan; 755(1):144-7. PubMed ID: 6297609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments.
    Johnson JD; Fugman DA
    J Pharmacol Exp Ther; 1983 Aug; 226(2):330-4. PubMed ID: 6875846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two types of calmodulin antagonists: a structurally related interaction.
    Inagaki M; Hidaka H
    Pharmacology; 1984; 29(2):75-84. PubMed ID: 6089236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Itoh H; Hidaka H
    J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of myristoylated N-terminal nonapeptide from neuro-specific protein CAP-23/NAP-22 to calmodulin does not induce the globular structure observed for the calmodulin-nonmyristylated peptide complex.
    Hayashi N; Izumi Y; Titani K; Matsushima N
    Protein Sci; 2000 Oct; 9(10):1905-13. PubMed ID: 11106163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myristoylation-regulated direct interaction between calcium-bound calmodulin and N-terminal region of pp60v-src.
    Hayashi N; Nakagawa C; Ito Y; Takasaki A; Jinbo Y; Yamakawa Y; Titani K; Hashimoto K; Izumi Y; Matsushima N
    J Mol Biol; 2004 Apr; 338(1):169-80. PubMed ID: 15050832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.